|
Volumn 12, Issue 10, 2005, Pages 1533-1539
|
Acceptability and tolerance of sodium valproate, a new sustained-action granule formulation, in monotherapy for epileptic children from 3 years old;Acceptabilité et tolérance du valproate de sodium, granules à libáration prolongée, en monothérapie chez l'enfant épileptique à partir de trois ans
|
Author keywords
Acceptability; Antiepileptic drugs; Children; Epilepsy; Galenic; Observance
|
Indexed keywords
MICROPAKINE;
VALPROIC ACID;
ARTICLE;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG GRANULE;
DRUG RELEASE;
DRUG SCREENING;
DRUG STABILITY;
DRUG TOLERABILITY;
EPILEPSY;
HUMAN;
INJECTION;
MAJOR CLINICAL STUDY;
MONOTHERAPY;
PARENT;
PATIENT COMPLIANCE;
PEDIATRICIAN;
RATING SCALE;
SEIZURE;
STATISTICAL SIGNIFICANCE;
SUSTAINED RELEASE FORMULATION;
TASTE;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ADOLESCENT;
ANTICONVULSANTS;
CHILD;
CHILD, PRESCHOOL;
DELAYED-ACTION PREPARATIONS;
EPILEPSY;
FEMALE;
HUMANS;
MALE;
PATIENT COMPLIANCE;
TASTE;
TREATMENT OUTCOME;
VALPROIC ACID;
|
EID: 26444452583
PISSN: 0929693X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.arcped.2005.07.009 Document Type: Article |
Times cited : (21)
|
References (9)
|